help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on May 16, 2007, doi:10.1164/rccm.200703-456SO
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200703-456SOv1
176/6/532    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabe, K. F.
Right arrow Articles by Zielinski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabe, K. F.
Right arrow Articles by Zielinski, J.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 532-555, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200703-456SO

Original Article

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

GOLD Executive Summary

Klaus F. Rabe1, Suzanne Hurd2, Antonio Anzueto3, Peter J. Barnes4, Sonia A. Buist5, Peter Calverley6, Yoshinosuke Fukuchi7, Christine Jenkins8, Roberto Rodriguez-Roisin9, Chris van Weel10 and Jan Zielinski11

1 Leiden University Medical Center, Pulmonology, Leiden, The Netherlands; 2 Global Initiative for Chronic Obstructive Lung Disease, Gaithersburg, Maryland; 3 University of Texas Health Science Center, San Antonio, Texas; 4 National Heart and Lung Institute, London, United Kingdom; 5 Oregon Health and Science University, Portland, Oregon; 6 University Hospital Aintree, Liverpool, United Kingdom; 7 Asian Pacific Society of Respirology, Tokyo, Japan; 8 Woolcock Institute of Medical Research, North Sydney, Australia; 9 Hospital Clinic, Barcelona, Spain; 10 University of Nijmegen, Nijmegen, The Netherlands; and 11 Institute of TB and Lung Diseases, Warsaw, Poland

Correspondence and requests for reprints should be addressed to Prof. Klaus F. Rabe, M.D., Ph.D., Leiden University Medical Center, Pulmonology, P.O. Box 9600, NL-2300 RC, Leiden, The Netherlands. E-mail: k.f.rabe{at}lumc.nl.

Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is the fourth leading cause of chronic morbidity and mortality in the United States, and is projected to rank fifth in 2020 in burden of disease worldwide, according to a study published by the World Bank/World Health Organization. Yet, COPD remains relatively unknown or ignored by the public as well as public health and government officials. In 1998, in an effort to bring more attention to COPD, its management, and its prevention, a committed group of scientists encouraged the U.S. National Heart, Lung, and Blood Institute and the World Health Organization to form the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Among the important objectives of GOLD are to increase awareness of COPD and to help the millions of people who suffer from this disease and die prematurely of it or its complications. The first step in the GOLD program was to prepare a consensus report, Global Strategy for the Diagnosis, Management, and Prevention of COPD, published in 2001. The present, newly revised document follows the same format as the original consensus report, but has been updated to reflect the many publications on COPD that have appeared. GOLD national leaders, a network of international experts, have initiated investigations of the causes and prevalence of COPD in their countries, and developed innovative approaches for the dissemination and implementation of COPD management guidelines. We appreciate the enormous amount of work the GOLD national leaders have done on behalf of their patients with COPD. Despite the achievements in the 5 years since the GOLD report was originally published, considerable additional work is ahead of us if we are to control this major public health problem. The GOLD initiative will continue to bring COPD to the attention of governments, public health officials, health care workers, and the general public, but a concerted effort by all involved in health care will be necessary.

Key Words: COPD • guidelines • human • chronic disease


Related articles in AJRCCM:

COPD Guidelines: The Important Thing Is Not to Stop Questioning
Leonardo M. Fabbri, Piera Boschetto, and Cristina E. Mapp
AJRCCM 2007 176: 527-528. [Full Text]  



This article has been cited by other articles:


Home page
 Eur Respir JHome page
O. N. Keene, P. M. A. Calverley, P. W. Jones, J. Vestbo, and J. A. Anderson
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
Eur. Respir. J., July 1, 2008; 32(1): 17 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. M. Clini and N. Ambrosino
Nonpharmacological treatment and relief of symptoms in COPD
Eur. Respir. J., July 1, 2008; 32(1): 218 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Wright, M. Cosio, and A. Churg
Animal models of chronic obstructive pulmonary disease
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Iwamoto, A. Yokoyama, N. Shiota, H. Shoda, Y. Haruta, N. Hattori, and N. Kohno
Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype
Eur. Respir. J., June 1, 2008; 31(6): 1379 - 1380.
[Full Text] [PDF]

Home page
 ChestHome page
Z. Ammous, N. R. Hackett, M. W. Butler, T. Raman, I. Dolgalev, T. P. O'Connor, B.-G. Harvey, and R. G. Crystal
Variability in Small Airway Epithelial Gene Expression Among Normal Smokers
Chest, June 1, 2008; 133(6): 1344 - 1353.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, P. Boschetto, and C. Mapp
Time to Wake Up!
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1291 - 1292.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D. Sin, S. F. P. Man, D. D. Marciniuk, G. Ford, M. FitzGerald, E. Wong, E. York, R. R. Mainra, W. Ramesh, L. S. Melenka, et al.
The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1207 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. D. Calvert, R. Shelley, S. J. Singh, P. L. Greenhaff, J. Bankart, M. D. Morgan, and M. C. Steiner
Dichloroacetate Enhances Performance and Reduces Blood Lactate during Maximal Cycle Exercise in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1090 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. E. Falagas, S. G. Avgeri, D. K. Matthaiou, G. Dimopoulos, and I. I. Siempos
Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis
J. Antimicrob. Chemother., May 8, 2008; (2008) dkn201v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. C. Hogg and R. A. Pierce
Remodelling of peripheral lung tissue in COPD
Eur. Respir. J., May 1, 2008; 31(5): 913 - 914.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
G. R. Washko, E. Hoffman, and J. J. Reilly
Radiographic Evaluation of the Potential Lung Volume Reduction Surgery Candidate
Proceedings of the ATS, May 1, 2008; 5(4): 421 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. L. Bayley, H. Abusriwil, A. Ahmad, and R. A. Stockley
Validation of assays for inflammatory mediators in exhaled breath condensate
Eur. Respir. J., May 1, 2008; 31(5): 943 - 948.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Sato, Y. Hoshino, T. Hara, S. Muro, H. Nakamura, M. Mishima, and J. Yodoi
Thioredoxin-1 Ameliorates Cigarette Smoke-Induced Lung Inflammation and Emphysema in Mice
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 380 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. B. Soriano and D. M. Mannino
Reversing concepts on COPD irreversibility
Eur. Respir. J., April 1, 2008; 31(4): 695 - 696.
[Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
J.F. Donohue, N.A. Hanania, K.A. Sciarappa, E. Goodwin, D.R. Grogan, R.A. Baumgartner, and J.P. Hanrahan
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 37 - 48.
[Abstract] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
K. M. Kunisaki, K. L. Rice, E. N. Janoff, T. S. Rector, and D. E. Niewoehner
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 55 - 64.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
L. D. Calvert, S. J. Singh, P. L. Greenhaff, M. D. Morgan, and M. C. Steiner
The plasma ammonia response to cycle exercise in COPD
Eur. Respir. J., April 1, 2008; 31(4): 751 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Vestbo, W. Anderson, H. O. Coxson, C. Crim, F. Dawber, L. Edwards, G. Hagan, K. Knobil, D. A. Lomas, W. MacNee, et al.
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Eur. Respir. J., April 1, 2008; 31(4): 869 - 873.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Watz, B. Waschki, C. Boehme, M. Claussen, T. Meyer, and H. Magnussen
Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity: A Cross-sectional Study
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 743 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Churg, M. Cosio, and J. L. Wright
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Calverley
Understanding Breathlessness in Mild Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 564 - 565.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Ofir, P. Laveneziana, K. A. Webb, Y.-M. Lam, and D. E. O'Donnell
Mechanisms of Dyspnea during Cycle Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 622 - 629.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Baraldo and M. Saetta
To reg or not to reg: that is the question in COPD
Eur. Respir. J., March 1, 2008; 31(3): 486 - 488.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Eur. Respir. J., March 1, 2008; 31(3): 502 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Singh
On Treating and Preventing Acute Exacerbations in COPD
Proceedings of the ATS, February 15, 2008; 5(2): 283 - 283.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Langsetmo, R. W. Platt, P. Ernst, and J. Bourbeau
Underreporting Exacerbation of Chronic Obstructive Pulmonary Disease in a Longitudinal Cohort
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 396 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
M. Poulain, M. Doucet, V. Drapeau, G. Fournier, A. Tremblay, P. Poirier, and F. Maltais
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Chronic Respiratory Disease, February 1, 2008; 5(1): 35 - 41.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Bozinovski, A. Hutchinson, M. Thompson, L. MacGregor, J. Black, E. Giannakis, A.-S. Karlsson, R. Silvestrini, D. Smallwood, R. Vlahos, et al.
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 269 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Derom, C. van Weel, G. Liistro, J. Buffels, T. Schermer, E. Lammers, E. Wouters, and M. Decramer
Primary care spirometry
Eur. Respir. J., January 1, 2008; 31(1): 197 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Shirtcliffe, M. Weatherall, and R. Beasley
From the authors
Eur. Respir. J., January 1, 2008; 31(1): 218 - 219.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 647 - 658.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D. C Grootendorst, S. A Gauw, R. M Verhoosel, P. J Sterk, J. J Hospers, D. Bredenbroker, T. D Bethke, P. S Hiemstra, and K. F Rabe
Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD
Thorax, December 1, 2007; 62(12): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D. Sin and W. C. Tan
Breaking Down the "Great Wall" of COPD Care in China
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 732 - 733.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, P. Boschetto, and C. E. Mapp
COPD Guidelines: The Important Thing Is Not to Stop Questioning
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 527 - 528.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
Recommendations for Management of COPD
Journal Watch (General), September 13, 2007; 2007(913): 2 - 2.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society